![]() |
Hormonal Deficiencies found in
Chronic Fatigue Syndrome
(Research on Fatigue
Symptom)
Taken from the MEssenger dated
April 1992 which was reprinted from Backgrounder - National Institute of
Allergy and Infectious Diseases, January
1992
New research has revealed sublte
hormonal deficiencies in the neuroendocrine systems of people with chronic
fatigue syndrome (CFS). These finding may explain many symptoms of the
disorder and could lead to new treatment strategies. The study was
conducted by a collaborative team of researchers from NIAID, the National
Institute of Mental Health and the National Institute of Child Health and
Human Development.
The hallmark of CFS is debilitating fatigue of
unknown causes lasting at least 6 months. Other common symptoms include
feaverishness, tender lymph glands, muscle and joint aches, sleep
disturbances, depression and difficulty concentrating.
The number
of people with CFS in the United States is unknown, but estimates range in
the tens of thousands. Although most people diagnosed with CFS are
young adult women, the conditon occurs in people of all ages and races and
of both sexes.
The research team found that, on average, levels of
the hormone cortisol were lower in the blood and urine of the 30 CFS
patients studied than in 72 healthy volunteers. Cortisol is secreted by
the adrenal gland in reponse to stress. It has long been known that even a
suble deficiency of cortisol can be associated with lethargy and
fatigue.
Normally, when the body responds to a stressor - whether
to a virus or bacterium, an environmental toxin, or a pshychological event
- a complex series of events occurs in the endocrine (hormone) system.
The hypothalamus, a small area at the base of the brain, first
secretes a brain chemical called corticotropin releasing hormone(CRH),
which activates the pituitary gland to secrete adrenocorticotropin hormone
(ACTH).
ACTH, in turn, stimulates the adrenal gland to produce
cortisol. This hormonal circut was examined in the 18 women and 12 men
with CFS in the study, all of whom met the criteria for CFS established by
the Centers for Disease control. None of the patients was allowed to use
drugs, alcohol, tobacco or caffeine for 2 weeks before the study began in
order not to compromise the results. All underwent a series of clinical
tests involving administration of small doses of CRH and ACTH.
The
levels of several hormones were subsequently analyzed in blood, urine, and
cerebrospinal fluid samples taken from the patients.
Based on their
findings, the investigators concluded that the cortisol deficiency seen in
patients with CFS resulted from a CRH deficiency.
In addition
to controlling ACTH and cortisol secretion, CRH helps to increase energy
lvels through its direct effect on the brain. Thus, two hormonal
abnormalities - a CRH deficiency and the resultant cortisol deficiency -
could each contribute to the overall symptoms and course of CFS, according
to the researchers.
The endocrine deficiency found in the study
patients also offers a possible explanation for the depressive symptoms
that may accommpany CFS. Although the hormone profile of the CFS
patients studied is the opposite of what is seen in "classic"melancholic
depression, low CRH levels have been seen in patients with other
depressive syndromes.
These syndromes include some traditionally
characterized as psychological disorders, such as specific subtypes of
major depression, as well as depressive syndromes associated with
Cushing's disease and hypothyroidism. Finding a common central nervous
system defect in these illnesses underscores the fact that these
depressive syndromes are all fundamentally physical illnesses caused by a
biochemical imbalance, according to the researchers. The
investigators suggest that insufficient stimulation of certain parts of
the brain by cortisol or CRH could account for the lethargy and increased
need for sleep seen in CFS. Further studies are in progress to
determine which contributes most significantly to the fatigue in patients
with CFS - the CRH deficiency or the cortisol deficiency alone, or the two
deficiencies together.
Importantly, among individual CFS patients,
the investigators found no associatioon between their hormone levels and a
past or present history of psychiatric illness.
Stephen E. Straus,
M.D., chief of MAID's Laboratory of Clinical Investigation and a
collaborator on the study, has investigated various aspects of CFS for the
past 12 years. He was originally intrigued by the possibilty that a
chronic infection could cause the disorder and might explain the high
levels of viral antibodies found in many people with CFS.
"There
continues to be hints of viruses being associated with CFS," Dr Straus
said, "but I am excited by the alternative new hypotheses raised about the
syndrome by the current findings. Because cortisol is a potent suppessor
of immune responses, a mild reduction in cortisol levels could allow the
immune system to remain overactive, leading to findings such as a
higher-than normal antibody levels".
Although the research findings
have not proved that low CRH and cortisol levels cause CFS, the
researchers said their results suggest that hormonal balance might be
restored by treating patients with small amounts of cortisol.
They
caution, however, that cortisol levels cannot be easily measured. In
additon, simply treating patients with cortisol could be dangerous.
Administering cortisol to a CFS patient could signal to the hypothalamus
that the supply of cortisol is adequate and that the secretion of CRH is
unnecessary. Thus, the CRH deficiency could be
exacerbated.
Despite these concerns, Dr. Straus said, "careful study could reveal a means to use the present findings to help alleviate the associated fatigue, lethargy, muscular aches and feverishness of CFS".
Reference:
mark Demitrack, Janet
Dale, Stephen Straus, Louisa Laue, Sam Liswak, Markus Kruesi, George
Chrousos, and Philip Gold.
"Evidence for Impaired Activation of the
Hypothalamic-Pituitary-Adrenal Axis in Patients with Chronic Fatigue
Syndrome" Jornal of Clincial Endrocrinology and Metabolism 73,
1224-34(1991).
University of Michigan Medical Center (M. Demitrack)
National Institute of Allergy and Infectious Diseases (J. Dale, S. Straus)
National Institute of Mental Health (S. Listwak, M. Kruesi, P. Gold)
Georgetown University Medical Centre (L.Laue).
If you are planning on
leaving after this page, please sign my guestbook.
Thanks!!
|
|
|
|
All content © 1998 - 2016 by Lady
Care's Realm on the Web.
All right reserved.
All other copyrights
belong to their respective holders.
All graphics © 1998 - 2016 Dream Web Designs
All right
reserved.
All other copyrights belong to their respective
holders.
This
background set made and copyrighted by Lady Care Designs.
Please do not
take any of the set or the graphic.
Thank you for respecting the
copyright
laws.